| Bioactivity | VX-166, a pan caspase inhibitor, can be used for the research of Non- Alcoholic Fatty Liver Disease (NAFLD), nonalcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH), and other diseases involving fibrosis, steatosis, or inflammation of the liver[1]. |
| CAS | 800408-39-3 |
| Formula | C22H21F4N3O8 |
| Molar Mass | 531.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. John Pollard, et al. Treatment of liver diseases with a caspase inhibitor. Patent WO2010120880A1. |